跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
METHYLDOPA TABLETS 125MG
Authorized
STANDARD
METHYLDOPA TABLETS 125MG
Laboratoires Confab Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
093dab56df16c63a
Company
Laboratoires Confab Inc
Type
Standard
Approval Details
Approval Id
093dab56df16c63a
Drug Approval Canada Name
METHYLDOPA TABLETS 125MG
Product Name
METHYLDOPA TABLETS 125MG
Status
Cancelled Pre Market
Status Date
2021-04-09
Din
02232648
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:08.16
Atc Original
C02AB01 METHYLDOPA (LEVOROTATORY)
Atc Name
c 02 ab 01
Aig Number
0100049003
Company Name
Laboratoires Confab Inc
Company Address
4355 Boul. Sir Wilfrid Laurier, St-Hubert, Quebec, Canada, J3Y 3X3
Company Detail Path
/organization/laboratoires-confab-inc
Company Information
Pharmaceutical Company Name
Laboratoires Confab Inc
Country Name
Canada
Province Name
Quebec
City Name
saint-hubert,quebec,country_ca
Address
4355 boul Sir-Wilfrid-Laurier
Active Ingredients
METHYLDOPA
125 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
093dab56df16c63a
Type
Standard
Back to Health Canada Approvals
METHYLDOPA TABLETS 125MG - Health Canada Drug Approval Details